Why in news?
- India and the U.S. plan to work together on vaccine research and testing for COVID-19.
- U.S. and Indian scientists have been collaborating on key research questions fostering the development and testing of safe, cost-effective vaccines against a range of infectious diseases that could save innumerable lives in India, the United States, and around the world.
U.S. – India Collaboration in COVID-19 response
VAP
- Under the Vaccine Action Programme (VAP) U.S. and India planning to collaborate on the development and testing of vaccine candidates and diagnostics for COVID-19,
- The VAP, or the Indo-U.S. Vaccine Action Program, is a 33-year collaboration between the U.S. National Institutes of Health, the Indian Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR) along with other partners.
U.S. funding Ventilators for India
- The United States Agency for International Development (USAID) is funding 200 ventilators given to India as announced by President Donald Trump.
- These ventilators are part of $5.9 million in funding announced to date for India, and that amount is a part of a worldwide commitment of $900 million made by U.S. to be available for combating the COVID-19 pandemic.
CDC funds
- The U.S. Centres for Disease Control and Prevention said it would separately fund the Government of India $3.6 million to support “prevention, preparedness, and response activities in India, in collaboration with and concurrence from the GoI.”
Click Here to Read more about USAID
-Source: The Hindu
